Showing results (641-650 of 687) with videos related to

Sort By:
Pageof 69
Biorxiv : the Preprint Server for Biology|April 10, 2023
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
Cancer Research Communications|August 7, 2023
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate CancerLucie Van Emmenis, Sheng-Yu Ku, Kaitlyn Gayvert, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 22, 2021
Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 InhibitorsMatthew J Mosquera, Sungwoong Kim, Rohan Bareja, et al.
Chest|January 31, 2017
Interventional Pulmonology Fellowship Accreditation Standards: Executive Summary of the Multisociety Interventional Pulmonology Fellowship Accreditation CommitteeJohn J Mullon, Kristin M Burkart, Gerard Silvestri, et al.
Nature Communications|November 20, 2024
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancerShankha S Chatterjee, Juan F Linares, Tania Cid-Diaz, et al.
Clinical Transplantation|June 24, 2023
Safety and utility of indwelling pleural catheters in lung transplant recipientsAnil J Trindade, Robert J Lentz, Whitney D Gannon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2018
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and BiomarkersHimisha Beltran, Clara Oromendia, Daniel C Danila, et al.
Cancer Discovery|March 6, 2012
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targetsHimisha Beltran, David S Rickman, Kyung Park, et al.
JACC. Cardiovascular Imaging|July 13, 2024
Rationale and Design of SCOT-HEART 2 Trial: CT Angiography for the Prevention of Myocardial InfarctionMichael McDermott, Mohammed N Meah, Phyo Khaing, et al.
Chest|November 13, 2019
The Impact of Gravity vs Suction-driven Therapeutic Thoracentesis on Pressure-related Complications: The GRAVITAS Multicenter Randomized Controlled TrialRobert J Lentz, Samira Shojaee, Horiana B Grosu, et al.
Pageof 69